AUPH - Spark Newswire

2 minute read

Aurinia Pharma Offers Updated Interim Results From AURORA 2 Continuation Study Of LUPYNIS For Treatment Of Lupus Nephritis

Today, 9:09 AM

- Longest available outcomes data with LUPKYNIS will be presented virtually during American College of Rheumatology (ACR) Convergence 2021; final results expected by the end of 2021 – - Updated interim analysis

AUPH

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 28, 2021

By Benzinga Insights

Today, 9:09 AM

AGNC

1 minute read

Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform, Raises Price Target to $32

By Benzinga Newsdesk

Today, 9:09 AM

Oppenheimer analyst Justin Kim downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Outperform to Perform and raises the price target from $28 to $32.

AUPH

2 minute read

Trump’s SPAC Partner Emerges As Top WallStreetBets Interest; Facebook, Snapchat, Tesla And These Are Other Top Trends

By Madhukumar Warrier

Today, 9:09 AM

Heading into a new trading week, Digital World Acquisition Corp. (NASDAQ: DWAC) has emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum, while Facebook Inc.

AMZN

5 minute read

55 Biggest Movers From Friday

By Lisa Levin

Today, 9:09 AM

Gainers

AGEN

6 minute read

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

By Shanthi Rexaline

Today, 9:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABEO

7 minute read

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

By Shanthi Rexaline

Today, 9:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)

ACAD

6 minute read

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

By Shanthi Rexaline

Today, 9:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)

ABT

3 minute read

Aurinia Pharma Shares Up 3.7% Following Earlier Press Release From Co. Disclosing It Entered Deal To Be Acquired By Unnamed ‘Pharma Behemoth’ At $35+/ADS

By Benzinga Newsdesk

Today, 9:09 AM

Aurinia Pharmaceuticals (NASDAQ:AUPH) (the “Company”) is pleased to announce that it will enter into a definitive agreement with a pharma behemoth. The leading pharmaceutical company is in talks with AUPH for

AUPH

1 minute read

Aurinia Adds Two Assets To Expand Its Immunology Pipeline

By Vandana Singh

Today, 9:09 AM

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200,…

AUPH

Feed Symbols: AUPH